Thrivent Financial for Lutherans Trims Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Thrivent Financial for Lutherans lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 330,948 shares of the medical equipment provider’s stock after selling 49,528 shares during the period. Thrivent Financial for Lutherans’ holdings in Intuitive Surgical were worth $172,955,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical in the 4th quarter valued at $25,000. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical during the fourth quarter worth about $26,000. BankPlus Trust Department acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth about $28,000. Kohmann Bosshard Financial Services LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $31,000. Finally, MidAtlantic Capital Management Inc. purchased a new stake in Intuitive Surgical during the 3rd quarter worth approximately $33,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In related news, EVP Brian Edward Miller sold 8,900 shares of the firm’s stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the transaction, the executive vice president now owns 5,758 shares of the company’s stock, valued at $2,793,033.06. This trade represents a 60.72 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Robert Desantis sold 11,545 shares of the company’s stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 33,754 shares of company stock valued at $17,691,621 over the last quarter. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $488.80 on Tuesday. The company has a market capitalization of $174.10 billion, a P/E ratio of 76.26, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The stock has a 50-day simple moving average of $566.38 and a 200-day simple moving average of $531.96.

Analyst Upgrades and Downgrades

Several equities analysts have commented on ISRG shares. Jefferies Financial Group boosted their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. CICC Research began coverage on Intuitive Surgical in a research report on Monday, January 27th. They issued a “neutral” rating and a $550.00 price target on the stock. UBS Group boosted their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. BTIG Research raised their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Finally, Bernstein Bank boosted their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $610.19.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.